CGTX vs. RXRX

Last updated Jun 6, 2026

CGTX (Cognition Therapeutics, Inc.) and RXRX (Recursion Pharmaceuticals, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 3 years, CGTX returned -23.93%/yr vs -27.31%/yr for RXRX. At a 0.24 correlation, their price movements are largely independent.

Performance

CGTX vs. RXRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cognition Therapeutics, Inc. (CGTX) and Recursion Pharmaceuticals, Inc. (RXRX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CGTX achieves a -4.44% return, which is significantly higher than RXRX's -18.95% return.

CGTX

• 1D: -5.15%
• 1M: 4.88%
• YTD: -4.44%
• 6M: -25.43%
• 1Y: 344.67%
• 3Y*: -23.93%
• 5Y*: —
• 10Y*: —

RXRX

• 1D: -12.76%
• 1M: -3.35%
• YTD: -18.95%
• 6M: -29.62%
• 1Y: -27.46%
• 3Y*: -27.31%
• 5Y*: -35.38%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CGTX vs. RXRX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
CGTX Cognition Therapeutics, Inc.	-4.44%	92.50%	-62.09%	-11.90%	-66.77%	-50.51%
RXRX Recursion Pharmaceuticals, Inc.	-18.95%	-39.50%	-31.44%	27.89%	-54.99%	-8.30%

Correlation

The correlation between CGTX and RXRX is 0.35, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.35
Correlation (3Y) Calculated over the trailing 3-year period	0.31
Correlation (All Time) Calculated using the full available price history since Oct 11, 2021	0.24

The correlation between CGTX and RXRX shifts across timeframes, from 0.24 (all time) to 0.35 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap CGTX : $115.06M RXRX : $1.75B
EPS CGTX : -$0.24 RXRX : -$1.17
PB Ratio CGTX : 3.85 RXRX : 1.71
Total Revenue (TTM) CGTX : $0.00 RXRX : $66.29M
Gross Profit (TTM) CGTX : -$129.00K RXRX : -$22.83M
EBITDA (TTM) CGTX : -$23.57M RXRX : -$505.90M

Return for Risk

CGTX vs. RXRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CGTX

CGTX Risk / Return Rank: 88
CGTX Sharpe Ratio Rank: 92
CGTX Sortino Ratio Rank: 90
CGTX Omega Ratio Rank: 88
CGTX Calmar Ratio Rank: 89
CGTX Martin Ratio Rank: 81

RXRX

RXRX Risk / Return Rank: 27
RXRX Sharpe Ratio Rank: 25
RXRX Sortino Ratio Rank: 28
RXRX Omega Ratio Rank: 28
RXRX Calmar Ratio Rank: 25
RXRX Martin Ratio Rank: 27

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CGTX vs. RXRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cognition Therapeutics, Inc. (CGTX) and Recursion Pharmaceuticals, Inc. (RXRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CGTX	RXRX	Difference
Sharpe ratio: Return per unit of total volatility	2.50	-0.37	+2.87
Sortino ratio: Return per unit of downside risk	3.11	-0.12	+3.23
Omega ratio: Gain probability vs. loss probability	1.39	0.99	+0.40
Calmar ratio: Return relative to maximum drawdown	4.27	-0.47	+4.75
Martin ratio: Return relative to average drawdown	6.88	-0.78	+7.66
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CGTX vs. RXRX - Sharpe Ratio Comparison

The current CGTX Sharpe Ratio is 2.50, which is higher than the RXRX Sharpe Ratio of -0.37. The chart below compares the historical Sharpe Ratios of CGTX and RXRX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CGTX	RXRX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.50	-0.37	+2.87
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.38	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.33	-0.38	+0.05

Drawdowns

CGTX vs. RXRX - Drawdown Comparison

The maximum CGTX drawdown since its inception was -98.16%, which is greater than RXRX's maximum drawdown of -93.13%. Use the drawdown chart below to compare losses from any high point for CGTX and RXRX.

Drawdown Indicators

	CGTX	RXRX	Difference
Max Drawdown Largest peak-to-trough decline	-98.16%	-93.13%	-5.03%
Max Drawdown (1Y) Largest decline over 1 year	-81.30%	-58.17%	-23.13%
Max Drawdown (3Y) Largest decline over 3 years	-92.93%	-82.09%	-10.84%
Max Drawdown (5Y) Largest decline over 5 years	—	-93.13%	—
Current Drawdown Current decline from peak	-90.06%	-91.98%	+1.92%
Average Drawdown Average peak-to-trough decline	-84.31%	-75.37%	-8.94%
Ulcer Index Depth and duration of drawdowns from previous peaks	50.37%	35.43%	+14.94%

Volatility

CGTX vs. RXRX - Volatility Comparison

Cognition Therapeutics, Inc. (CGTX) and Recursion Pharmaceuticals, Inc. (RXRX) have volatilities of 23.61% and 24.76%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CGTX	RXRX	Difference
Volatility (1M) Calculated over the trailing 1-month period	23.61%	24.76%	-1.15%
Volatility (6M) Calculated over the trailing 6-month period	73.91%	46.84%	+27.07%
Volatility (1Y) Calculated over the trailing 1-year period	139.37%	74.19%	+65.18%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	119.02%	93.70%	+25.32%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	119.02%	93.79%	+25.23%

Dividends

CGTX vs. RXRX - Dividend Comparison

Neither CGTX nor RXRX has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both CGTX and RXRX in my portfolio?

CGTX and RXRX have a correlation of 0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CGTX or RXRX?

RXRX has higher volatility (24.76%) compared to CGTX (23.61%). In terms of maximum drawdown, CGTX dropped -98.16% vs RXRX's -93.13%.

Which has better risk-adjusted returns?

CGTX currently has the higher Sharpe Ratio (2.50 vs -0.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.